multi-targeted kinase inhibitors market
is expected to benefit from the growing acceptance of the undisputable fact that the battle against cancer can be horned not by blocking out tumor cells at one point, but by simultaneously blocking multiple biological triggers and pathways, given the tendency of these cells to regroup to recalibrate and spread through new growth paths.
Global sales of Gleevec are projected to steadily increase between the period 2010 and 2015, as stated by the new market research report. New generation kinase inhibitor drugs like Nexavar are forecast to witness robust growth over the period 2006 through 2015.
Leading players operating in the marketplace include Amgen Inc, Novartis, AstraZeneca plc, Genentech, Roche, OSI Pharmaceuticals, Pfizer, Bristol-Myers Squibb, Glaxo SmithKline, Wyeth, Onyx Pharmaceuticals Inc., Merck & Co. Inc, KAI Pharmaceuticals Inc, Celgene Corporation, Sanofi-Aventis, and Bayer Schering Pharma AG, among others.
The report titled "Small Molecule Kinase Inhibitors: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of industry overview, technology, trends, growth drivers, challenges, and most promising drugs in pipeline. Also provided are profiles of major players, and an enumeration of recent developments, mergers, acquisitions, and other strategic industry activities. Global small molecule kinase inhibitors market is a
Page: 1 2 3 Related biology technology :1
Copyright©2009 Vocus, Inc.
All rights reserved
. Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.2
. Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes3
. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales4
. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market5
. deCODE Reinstated to Nasdaq Global Market6
. BIO Ventures for Global Health Announces Management Changes7
. World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.8
. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)9
. Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels10
. BD and FIND Achieve Milestone in Global Battle Against MDR-TB11
. Springborn Deploys eStudy(TM) Hosted Solution for Management of Global Environmental Testing